Feifei Cheng
Impact in
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Geriatrics and Gerontology top 10%
- Sirtuins and Resveratrol in Medicine
Papers in
-
- Enzyme Catalysis and Immobilization 3
- Epigenetics and DNA Methylation 2
- Retinal Development and Disorders 2
-
- Cancer Genomics and Diagnostics 2
- Cancer, Hypoxia, and Metabolism 2
- Co-authors
- Cheng Qian (5 shared papers)Li Su (4 shared papers)Zi‐Bing Jin (7 shared papers)Junjie Shen (4 shared papers)Juanjuan Shan (4 shared papers)Limei Liu (4 shared papers)Jun Chen (4 shared papers)Xue‐Bi Cai (2 shared papers)
- Journals
- Cancer Letters (2 papers)Oncotarget (2 papers)Chirality (2 papers)Investigative Ophthalmology & Visual Science (2 papers)Nature Communications (1 paper)
- Partner nations
- ChinaAustraliaUnited States
In The Last Decade
Feifei Cheng
21 papers receiving 752 citations
Peers
Comparison fields: 5 of 90
- Cancer Research 282
- Geriatrics and Gerontology 38
- Oncology 148
- Molecular Biology 351
- Pathology and Forensic Medicine 60
Countries citing papers authored by Feifei Cheng
This map shows the geographic impact of Feifei Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feifei Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feifei Cheng more than expected).
Fields of papers citing papers by Feifei Cheng
This network shows the impact of papers produced by Feifei Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feifei Cheng. The network helps show where Feifei Cheng may publish in the future.
Co-authors
The 25 scholars most cited alongside Feifei Cheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 285 | |
| 2 | 2016 | 85 | |
| 3 | 2017 | 68 | |
| 4 | 2016 | 58 | |
| 5 | 2017 | 56 | |
| 6 | 2016 | 38 | |
| 7 | 2016 | 33 | |
| 8 | 2017 | 22 | |
| 9 | 2018 | 19 | |
| 10 | 2022 | 17 | |
| 11 | 2021 | 15 | |
| 12 | 2019 | 13 | |
| 13 | 2016 | 10 | |
| 14 | 2016 | 9 | |
| 15 | 2024 | 8 | |
| 16 | 2018 | 8 | |
| 17 | 2018 | 6 | |
| 18 | 2025 | 4 | |
| 19 | 2023 | 3 | |
| 20 | 2019 | 2 |
About Feifei Cheng
Feifei Cheng is a scholar working on Molecular Biology, Cancer Research, Oncology, Organic Chemistry and Genetics, having authored 22 papers that have together received 760 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (4 papers), Enzyme Catalysis and Immobilization (3 papers), Cancer Genomics and Diagnostics (2 papers), Carbohydrate Chemistry and Synthesis (2 papers), Epigenetics and DNA Methylation (2 papers), Retinal Development and Disorders (2 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Cyclopropane Reaction Mechanisms (1 paper). The work is most often cited by research in Cancer Research (282 citations), Geriatrics and Gerontology (38 citations), Oncology (148 citations), Molecular Biology (351 citations) and Pathology and Forensic Medicine (60 citations). Feifei Cheng has collaborated with scholars based in China, Australia and United States. Frequent co-authors include Cheng Qian, Li Su, Zi‐Bing Jin, Junjie Shen, Juanjuan Shan, Limei Liu, Jun Chen, Xue‐Bi Cai, Yongli Luo and Chao Yao. Their work appears in journals such as Cancer Letters, Oncotarget, Chirality, Investigative Ophthalmology & Visual Science and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.